Replies to post #117725 on Biotech Values

[jq1234]

At what point would you no longer consider Pona "high" risk?

High risk is relative to valuation. If ARIA were $500m company, I wouldn't consider it high risk. As I said, I like ARIA. But for a billion dollar company, either has to have big pipeline or a platform. In oncology, there is no shoo in.

but that doesn't prevent someone from making a hostile offer.

Don't hold your breath.